AP251A - Dichloroaniline compound. - Google Patents
Dichloroaniline compound. Download PDFInfo
- Publication number
- AP251A AP251A APAP/P/1991/000271A AP9100271A AP251A AP 251 A AP251 A AP 251A AP 9100271 A AP9100271 A AP 9100271A AP 251 A AP251 A AP 251A
- Authority
- AP
- ARIPO
- Prior art keywords
- compound
- formula
- amino
- solution
- evaporated
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB909012465A GB9012465D0 (en) | 1990-06-05 | 1990-06-05 | Chemical compounds |
| GB919104645A GB9104645D0 (en) | 1991-03-05 | 1991-03-05 | Chemical compound |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AP9100271A0 AP9100271A0 (en) | 1991-07-31 |
| AP251A true AP251A (en) | 1993-04-20 |
Family
ID=26297165
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| APAP/P/1991/000271A AP251A (en) | 1990-06-05 | 1991-06-04 | Dichloroaniline compound. |
Country Status (25)
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9104650D0 (en) * | 1991-03-05 | 1991-04-17 | Glaxo Group Ltd | Medicaments |
| ZA994264B (en) | 1998-07-01 | 2000-01-25 | Warner Lambert Co | Stereoisomers with high affinity for adrenergic receptors. |
| US7232837B2 (en) | 1999-06-29 | 2007-06-19 | Mcneil-Ppc, Inc. | Stereoisomers with high affinity for adrenergic receptors |
| GB0014546D0 (en) | 2000-06-14 | 2000-08-09 | Glaxo Group Ltd | A novel process |
| FR2960153B1 (fr) * | 2010-05-20 | 2012-08-17 | Centre Nat Rech Scient | Nouveaux bras autoreactifs et prodrogues les comprenant |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3536712A (en) * | 1966-09-22 | 1970-10-27 | Boehringer Sohn Ingelheim | 1-(amino-dihalo-phenyl)-2-amino-ethanes and -ethanols and salts thereof |
| US4396627A (en) * | 1979-06-16 | 1983-08-02 | Beecham Group Limited | Secondary amines, their preparation and use in pharmaceutical compositions |
| GB2187734A (en) * | 1986-02-12 | 1987-09-16 | Glaxo Group Ltd | Dichloroaniline derivatives |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8426191D0 (en) * | 1984-10-17 | 1984-11-21 | Glaxo Holdings Ltd | Chemical compounds |
| ES8802416A1 (es) * | 1986-04-15 | 1988-06-01 | Glaxo Group Ltd | Un procedimiento para la preparacion de derivados de dicloroanilina. |
-
1991
- 1991-06-04 DE DE4118293A patent/DE4118293A1/de not_active Withdrawn
- 1991-06-04 ES ES9101342A patent/ES2036920B1/es not_active Expired - Fee Related
- 1991-06-04 KR KR1019910009211A patent/KR920000717A/ko not_active Application Discontinuation
- 1991-06-04 GB GB9111946A patent/GB2244709B/en not_active Expired - Fee Related
- 1991-06-04 MY MYPI91000987A patent/MY106672A/en unknown
- 1991-06-04 DK DK106991A patent/DK106991A/da not_active Application Discontinuation
- 1991-06-04 OA OA60012A patent/OA09501A/xx unknown
- 1991-06-04 AT AT0112891A patent/AT399874B/de not_active IP Right Cessation
- 1991-06-04 FI FI912679A patent/FI912679A/fi not_active Application Discontinuation
- 1991-06-04 CH CH1651/91A patent/CH682322A5/fr not_active IP Right Cessation
- 1991-06-04 CA CA002043850A patent/CA2043850A1/en not_active Abandoned
- 1991-06-04 AP APAP/P/1991/000271A patent/AP251A/en active
- 1991-06-04 IE IE189891A patent/IE911898A1/en unknown
- 1991-06-04 LU LU87945A patent/LU87945A1/fr unknown
- 1991-06-04 FR FR9106741A patent/FR2662691A1/fr active Granted
- 1991-06-04 IL IL98363A patent/IL98363A0/xx unknown
- 1991-06-04 EP EP91305057A patent/EP0460924A1/en not_active Withdrawn
- 1991-06-04 SE SE9101687A patent/SE500706C2/sv unknown
- 1991-06-04 IT ITRM910387A patent/IT1245868B/it active IP Right Grant
- 1991-06-04 AU AU78127/91A patent/AU635424B2/en not_active Ceased
- 1991-06-04 NL NL9100960A patent/NL9100960A/nl not_active Application Discontinuation
- 1991-06-04 GR GR910100242A patent/GR1001309B/el unknown
- 1991-06-04 BE BE9100536A patent/BE1005612A5/fr not_active IP Right Cessation
- 1991-06-04 JP JP3159631A patent/JPH05117236A/ja active Pending
- 1991-06-04 PT PT97858A patent/PT97858A/pt not_active Application Discontinuation
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3536712A (en) * | 1966-09-22 | 1970-10-27 | Boehringer Sohn Ingelheim | 1-(amino-dihalo-phenyl)-2-amino-ethanes and -ethanols and salts thereof |
| US4396627A (en) * | 1979-06-16 | 1983-08-02 | Beecham Group Limited | Secondary amines, their preparation and use in pharmaceutical compositions |
| GB2187734A (en) * | 1986-02-12 | 1987-09-16 | Glaxo Group Ltd | Dichloroaniline derivatives |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5273986A (en) | Cycloalkylthiazoles | |
| SK175398A3 (en) | Spiro-piperidine derivatives and their use as therapeutic agents | |
| PL151050B1 (en) | Method for manufacturing new dichloraniline derivatives | |
| US5254557A (en) | Compound and treatment | |
| JPS62155250A (ja) | フエノキシアルキルカルボン酸およびエステル化合物，その製造方法および該化合物を含有する医薬組成物 | |
| JPH10182583A (ja) | 新規ヒドロキサム酸誘導体 | |
| JPH1180131A (ja) | エチニルピリミジン誘導体 | |
| KR100192622B1 (ko) | 페네타놀아민 화합물 | |
| CZ282400B6 (cs) | Benzpyranové sloučeniny, způsob jejich přípravy, způsob přípravy meziproduktů, farmaceutický prostředek a použití těchto sloučenin | |
| RU2162470C2 (ru) | 2,7-замещенные производные октагидропирроло[1,2-а]пиразина, способ лечения, фармацевтическая композиция, промежуточные соединения | |
| AP251A (en) | Dichloroaniline compound. | |
| JP3616555B2 (ja) | そう痒症を処置するための新規な４−アリールピペリジン誘導体 | |
| EP1439164B1 (en) | Novel phenylethanolamine compounds having beta2-acceptor excitatory function and their preparation method | |
| KR0175532B1 (ko) | 벤조피란 및 이를 함유하는 제약 조성물 | |
| KR880002412B1 (ko) | 치환된 헥사하이드로벤조 [e]인덴 및 옥타하이드로페난트렌의 제조방법 | |
| US6518282B1 (en) | 4-Arylpiperidine derivatives for the treatment of pruritus | |
| US4275219A (en) | Novel process and intermediates useful in the preparation of sympathomimetic amines | |
| US4808604A (en) | N-(substituted phenyl) tetrazol-5-yl carboxamides and anti-allergic use thereof | |
| US6124457A (en) | Process and intermediates for a β3 -adrenergic receptor agonist | |
| US5821245A (en) | Use of naphthalene derivatives in treating lung carcinoma | |
| US4757078A (en) | Cyclic aryl hydroxamic acids, derivatives thereof and method of use as anti-allergy agents | |
| PL158165B1 (pl) | Sposób wytwarzania acylowych pochodnych hydroksypirymidyn PL PL PL PL | |
| JP2004509897A (ja) | シクロヘキシルアミン誘導体の立体選択的製造方法 | |
| US5776945A (en) | 4A-aryldecahydroisoquinoline compound and medicinal use of the same | |
| JP2001354655A (ja) | ２，３−ジ置換ピリジン誘導体からなる医薬 |